Helius Medical Technologies Inc (NASDAQ:HSDT) shares are rising Monday after the company announced a positive outcome from the Portable Neuromodulation Stimulator (PoNS) Stroke Registrational Program.

Thousands of Australians have received a device meant to ease chronic pain. Private health insurers say there is ample evidence it can do more harm than good for many of them.

Since 1980, Joseph Jeanmarie dealt with the pain, mostly working at a pain level of eight out of 10. Now, new technology his helping him get his life back.

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain's ability to ...

The Company’s first commercial product is the Portable Neuromodulation Stimulator. For more information about the PoNS or Helius Medical Technologies, visit www.heliusmedical.com.

NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and ...

NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance ...

Medical students fret over the new student loan cap in the 'big, beautiful bill' The bill will cap total medical loans at $200,000 — far below the more than $300,000 median cost of attending ...

Can a Medical Device Restore Your Balance? Nearly two million people worldwide have lost the simple ability to feel steady. Now researchers have developed an experimental medical implant that ...

Erik Menendez Diagnosed With "Serious Medical Condition" As Erik Menendez and brother Lyle Menendez await a parole hearing, lawyer Mark Geragos shared that Erik, 54, is battling a serious health ...